Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationGordon J. Freeman, Tasuku Honjo, Heidi F. Horton et al.|The Journal of Experimental Medicine|2000Cited by 5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activationYvette Latchman, Gordon J. Freeman, Clive R. Wood et al.|Nature Immunology|2001Cited by 2.9k
Necessity of Lysophosphatidic Acid Receptor 1 for Development of ArthritisYoshishige Miyabe, Toshihiro Nanki, Chie Miyabe et al.|Arthritis & Rheumatism|2013Cited by 83
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancerFumihiko Ando, Yoshiko Iwai|Frontiers in Pharmacology|2024Cited by 6
Clinical significance of PD-1-binding soluble PD-L1 and MMPs in the microenvironment of gastric cancer and non-small cell lung cancer treated with PD-1/PD-L1 blockadeFumihiko Ando, Yoshiko Iwai|medRxiv|2024Cited by 0